AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2015
May 6, 2015
32163_dirs_2015-05-06_2d4f495d-0a8b-484c-be16-201898b15e67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-05-06
Reporting Person: BOHLIN GAREN G (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Purchase) | $5.73 | 2025-03-19 | Common Stock (28985) | Direct |
Footnotes
F1: 2,415 options are fully exercisable. The remaining options vest in equal monthly increments of 604 shares per month for 43 months with 598 shares vesting on the first of the 44th month.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26